about
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disordersUsers' motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal storiesAttitudes towards the sharing of genetic information with at-risk relatives: results of a quantitative surveyParticipant use and communication of findings from exome sequencing: a mixed-methods study.Characterizing genetic variants for clinical actionBuilding the evidence base for decision making in cancer genomic medicine using comparative effectiveness researchReturn of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT).Psychological and behavioural impact of returning personal results from whole-genome sequencing: the HealthSeq projectFindings made in gene panel to whole genome sequencing: data, knowledge, ethics - and consequences?Cancer screening and genetics: a tale of two paradigmsParents' preferences for return of results in pediatric genomic research.Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability.The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop.Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and designImplementation and utilization of genetic testing in personalized medicine.Genomics and perinatal careAn epidemiological perspective on the future of direct-to-consumer personal genome testing.Personal genetics: regulatory framework in Europe from a service provider's perspective.Personalizing health care: feasibility and future implications.'Information is information': a public perspective on incidental findings in clinical and research genome-based testingPolicy perspectives on the emerging pathways of personalized medicineSocietal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment.Direct-to-consumer genomics on the scales of autonomy.Integrating genetic studies of nicotine addiction into public health practice: stakeholder views on challenges, barriers and opportunitiesThe cost-effectiveness of returning incidental findings from next-generation genomic sequencing.Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing.Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening.Legislation on direct-to-consumer genetic testing in seven European countries.Perceived ambiguity as a barrier to intentions to learn genome sequencing results.Parents' perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disordersPersonal utility and genomic information: look before you leapGenomic newborn screening: public health policy considerations and recommendations.Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencingWas it worth it? Patients' perspectives on the perceived value of genomic-based individualized medicine.Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project.Translational Genomic Research: Protocol Development and Initial Outcomes following SNP Testing for Colon Cancer Risk.Defining Ourselves: Personal Bioinformation as a Tool of Narrative Self-Conception.The beliefs, motivations, and expectations of parents who have enrolled their children in a genetic biorepositoryGenetic counseling as a tool for type 2 diabetes prevention: a genetic counseling framework for common polygenetic disorders.Patients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment
P2860
Q22330767-2A374F70-6726-4538-A276-3843F3062104Q24635266-7D44F0DD-40C9-4EA2-B863-EF93843842C8Q27320580-720F37CD-35E2-4BC8-971F-426503321DCBQ27324155-1D7DF73D-2140-4A10-AED7-FEF3EC68DF86Q28655937-512866C5-34FD-409E-A8E3-EE25FBD4C174Q30419845-0BEFC804-5EA6-40C4-98AC-303ACC4ED6FCQ30557139-0767B99E-037C-4D30-B4B8-A8C5ACA87E86Q30839097-34870237-311C-494B-A506-07BBAA7978C3Q31114379-08F2DC99-15A3-451D-911D-A65E3C533EFBQ33717364-3AE9459D-41D1-484C-BF9B-1D0A05E75F8BQ33815053-9DAB46C8-05D8-4849-95DD-DAAB2BD1155DQ33847214-F64C9E7C-2285-46FA-8189-F3DA49DDDBD0Q34113976-6A6FADEB-E819-4149-961C-DCB798894003Q34132349-828D6C1C-4B43-4636-AC14-B755E7FDB20BQ34147916-8F98E8B9-0DE4-418A-87C1-96979ABF349EQ34244450-874BB18B-2D38-41DD-B792-C8B22A248099Q34344701-A66DBB67-6E26-4134-AA56-6846C19DE53DQ34694691-5D825F63-1965-45ED-A655-36CE47AF335AQ34938911-279DB12F-C190-4982-9793-700BB6CC19C5Q35101415-1653798C-8ED7-4BD6-AF3E-42DDE4E1D876Q35237136-AAB1ED40-838E-4C51-8635-DAF4F9BA85BDQ35287159-1AA677BF-97D7-4861-9C0F-107BE5ECB5E8Q35351251-A75ED19D-6E35-44DC-BE3C-3E735B983075Q35576352-BD2ED019-2BC1-41D5-A25D-D6D25D8DC962Q35602902-E1B34E85-8346-4710-8ACE-D3E1DFD5E919Q35671138-05A3BB04-2F39-4D42-B2D6-56E6D7B3BBC2Q35822142-3FF43532-3595-47E4-9C47-807A2A8FF196Q36035698-EE9D5E34-1444-424E-A924-1EED4314E2BBQ36055126-C7460308-1B39-40D0-9552-BCAD0010EBA7Q36068717-8EFB9855-A4C5-4AEF-B8BC-2DCEA6FF373AQ36158668-4521F5B6-6898-4593-9278-0D555D1E522CQ36286855-9DF30BEB-E0B3-47AF-9131-4563A5F04565Q36371768-048B3BA7-5B82-404C-BD55-CE582FBD174DQ36698414-0331D964-4B2A-4EBD-B955-A1458E8CD6B6Q36724985-22DFFBC6-7F24-44D7-8855-20E9319A1131Q36738056-AB9B8D7A-4EC9-487F-BFB5-C5240EEA04ABQ36772851-3CE83BFF-47BA-446B-A2E8-A7EF538D193FQ37148886-FA15C3F7-5E98-480D-83AC-059885F5914FQ37312886-1C737A70-49A6-4FDC-839D-740468D811F1Q37410709-30457576-8808-41D2-AED2-53D0DC9FD66B
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Evaluating the utility of personal genomic information.
@en
Evaluating the utility of personal genomic information.
@nl
type
label
Evaluating the utility of personal genomic information.
@en
Evaluating the utility of personal genomic information.
@nl
prefLabel
Evaluating the utility of personal genomic information.
@en
Evaluating the utility of personal genomic information.
@nl
P2860
P1433
P1476
Evaluating the utility of personal genomic information.
@en
P2093
John J Mulvihill
Morris W Foster
P2860
P2888
P304
P356
10.1097/GIM.0B013E3181A2743E
P407
P577
2009-08-01T00:00:00Z
P6179
1041548480